A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing antibody (bnAb) administered prior to virus exposure protects macaques from ...

Fans don't think that the two colors in the Super Bowl 2025 logo — red and green — are a coincidence Skyler Caruso is a Writer and Reporter of PEOPLE Digital Entertainment. She joined PEOPLE ...

America’s ultimate ex-bureaucrat may not be out of the woods yet. South Carolina Attorney General Alan Wilson leads a 17 ...

DARE-HPV is a proposed treatment for HPV-related cervical diseases, supported by up to $2 million in NIAID grants. Daré Bioscience, Inc. has announced the development of DARE-HPV, an ...

Federal health officials say a dairy worker in Nevada has been infected with a new type of bird flu that's different from the version that has been spreading in U.S. herds since last year.

(NASDAQ: DARE), a biopharmaceutical company focused on women's health, has been awarded a Notice of Award of a grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of ...

New York on Friday ordered a weeklong shutdown of all live bird markets in New York City, Westchester and Long Island after ...